Pilulka Lékárny a.s.
I · AI Analysis
The brief
Pilulka runs pharmacy websites — Pilulka.cz and Pilulka.sk — and physical pharmacy locations, selling prescription drugs, dietary supplements, cosmetics, sports nutrition, baby products, and consumer electronics [Yahoo Finance]. The business model combines e-commerce distribution with traditional pharmacy services in the Czech Republic [Yahoo Finance].
Pilulka Lékárny operates a network of online and brick-and-mortar pharmacies in the Czech Republic and Slovakia, selling medicines, supplements, cosmetics, and consumer health products [Yahoo Finance]. The company is unprofitable, with trailing-twelve-month revenue of CZK 876.4M and a net loss of CZK 38.6M [Yahoo Finance]. Strategic or insider holders control 50.1% of shares, while the remaining public float trades on the Prague Stock Exchange [Yahoo Finance].
The company is loss-making, burning cash, and lacks coverage from analysts or institutional investors.
Sentinellis health
Significant risks
0.9/10
7.5+ strong · 4.5–7.5 moderate · under 4.5 weak
Profitability
Returns on capital
Growth & momentum
Balance sheet
Cash generation
Value creation
Sentinellis calculation from the published statements — not a score reported by any data source. Each category is scored on the checks that had data; missing inputs are excluded rather than counted as failures.
Market capitalisation
CZK 243.6M
Revenue (TTM)
CZK 876.4M
Explainers
How we read these numbers
Plain-English guides · no account needed
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
ReadPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
ReadAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
ReadPremium · Free with any account
Revenue contracted 32.8% year-over-year in the last fiscal year, a steep decline that raises questions about competitive position, pricing pressure, or demand erosion [Yahoo Finance].
Risks
6
Opportunities
3
Red flags
4
Leadership
2
12 more findings in the full report — free with any account.
Unlock the full Pilulka Lékárny a.s. analysis
Create a free account to access the complete AI-generated report with inline citations.
- 6 risks, 3 opportunities and 4 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare — or comparable health
Want this for your watchlist?